References
- World Health OrganizationThe top 10 causes of death2017 Available from: http://www.who.int/mediacentre/factsheets/fs310/enAccessed January 13, 2017
- BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD study): a population-based prevalence surveyLancet2007370958974175017765523
- MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax2009641086386819553233
- CsikeszNGGartmanEJNew developments in the assessment of COPD: early diagnosis is keyInt J Chron Obstruct Pulmon Dis2014927728624600220
- MenezesAMPerez-PadillaRJardimJRChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
- MaioSBaldacciSCarrozziLRespiratory symptoms/diseases prevalence is still increasing: a 25-yr population studyRespir Med2016110586526614595
- ChuchalinAGKhaltaevNAntonovNSChronic respiratory diseases and risk factors in 12 regions of the Russian FederationInt J Chron Obstruct Pulmon Dis2014996397425246783
- BelevskiyAGARD in Russia Available from: http://www.who.int/gard/news_events/GARD%20in%20Russia.pdfAccessed January 13, 2017
- AndreevaEPokhaznikovaMLebedevAMoiseevaIKutznetsovaODegryseJMThe prevalence of chronic obstructive pulmonary disease by the Global Lung Initiative equations in north-western RussiaRespiration2016911435526727503
- ArtyukhovIPArshukovaILDobretsovaEADuginaTAShulminAVDemkoIVEpidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, RussiaInt J Chron Obstruct Pulmon Dis2015101781178626366070
- Global adult tobacco survey (GATS): Russian Federation 2009 – country report Available from: http://www.who.int/entity/tobacco/surveillance/en_tfi_gats_russian_countryreport.pdfAccessed January 13, 2017
- ZbozinkovaZBarczykATkacovaRPOPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern EuropeInt J Chron Obstruct Pulmon Dis20161161162227042048
- PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990525210450
- WurstKEShuklaAMuellerovaHDavisKJRespiratory pharmacotherapy use inpatients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort studyCOPD201411552153024945236
- BarrechegurenMMonteagudoMFerrerJTreatment patterns in COPD patients newly diagnosed in primary care: a population-based studyRespir Med2016111475326758585
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- JonesPWHardingGBerryPWiklundIChenWHLeidyNKDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
- JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185Suppl B25311759018
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of COPDBethesda, MDGOLD2014
- MiravitllesMSoler-CataluñaJJCalleMSpanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPDArch Bronconeumol201248724725722561012
- LlordésMJaénAAlmagroPPrevalence, risk factors and diagnosis accuracy of COPD among smokers in primary careCOPD201512440441225474184
- Fernández-VillarALópez-CamposJLRepresas-RepresasCFactors associated with inadequate diagnosis of COPD: On-Sint cohort analysisInt J Obstruct Pulmon Dis201510961967
- MiravitllesMHuertaAFernández-VillarAGeneric utilities in chronic obstructive pulmonary disease patients stratified according to different staging systemsHealth Qual Life Outcomes20141212025189786
- CasanovaCMarínJMMartínez-GonzálezCDifferential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPDChest2015148115916825612228
- JonesPWNadeauGSmallMAdamekLCharacteristics of a COPD population categorized using the GOLD framework by health status and exacerbationsRespir Med2014108112913524041746
- AgustiAEdwardsLDCelliBCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortEur Respir J201342363664623766334
- BarrechegurenMRomán-RodríguezMMiravitllesMIs a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Int J Chron Obstruct Pulmon Dis2015101745175226366067
- HardinMSilvermanEKBarrRGThe clinical features of overlap between COPD and asthmaRespir Res20111212721951550
- MiravitllesMBarrechegurenMRoman-RodriguezMFrequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis201519899299826162367
- CosíoBGSorianoJBLópez-CamposJLDistribution and outcomes of a phenotype-based approach to guide COPD management: results from the CHAIN cohortPLoS One2016119e016077027684372
- KimVHanMKVanceGBThe chronic bronchitic phenotype of COPD: an analysis of the COPD Gedne studyChest2011140362663321474571
- MenezesAMde OcaMMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
- PerezXWisniveskyJPLurslurchachaiLBarriers to adherence to COPD guidelines among primary care providersRespir Med2012106337438122000501
- SalinasGDWilliamsonJCKalhanRBarriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physiciansInt J Chron Obstruct Pulmon Dis2011617117921468169